113 related articles for article (PubMed ID: 33749421)
1. Association of Weight Change, Inflammation Markers and Disease Staging with Survival of Patients Undergoing Chemotherapy for Pancreatic Adenocarcinoma.
Vasconcelos de Matos L; Coelho A; Cunha R; Fernandes L; Fontes E Sousa M; Neves MT; Cardoso D; Malheiro M; Graça J; Santos Silva E; Plácido A; Martins A
Nutr Cancer; 2022; 74(2):546-554. PubMed ID: 33749421
[TBL] [Abstract][Full Text] [Related]
2. Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT.
Alagappan M; Pollom EL; von Eyben R; Kozak MM; Aggarwal S; Poultsides GA; Koong AC; Chang DT
Am J Clin Oncol; 2018 Mar; 41(3):242-247. PubMed ID: 26757436
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma.
McLellan P; Henriques J; Ksontini F; Doat S; Hammel P; Desrame J; Trouilloud I; Louvet C; Pietrasz D; Vernerey D; Bachet JB
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101541. PubMed ID: 33055007
[TBL] [Abstract][Full Text] [Related]
4. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
5. Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy.
Luo G; Guo M; Liu Z; Xiao Z; Jin K; Long J; Liu L; Liu C; Xu J; Ni Q; Yu X
Ann Surg Oncol; 2015 Feb; 22(2):670-6. PubMed ID: 25155401
[TBL] [Abstract][Full Text] [Related]
6. A promising prognostic grading system incorporating weight loss and inflammation in patients with advanced cancer.
Zhang X; Huang JX; Tang M; Zhang Q; Deng L; Song CH; Li W; Shi HP; Cong MH
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2969-2980. PubMed ID: 37985353
[TBL] [Abstract][Full Text] [Related]
7. Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma.
Brkic FF; Kadletz L; Jank B; Mayer C; Heiduschka G; Brunner M
J Craniomaxillofac Surg; 2020 Jan; 48(1):33-37. PubMed ID: 31810849
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy.
Shin K; Jung EK; Park SJ; Jeong S; Kim IH; Lee MA
World J Gastrointest Oncol; 2021 Aug; 13(8):915-928. PubMed ID: 34457195
[TBL] [Abstract][Full Text] [Related]
9. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study.
Feliciano EMC; Kroenke CH; Meyerhardt JA; Prado CM; Bradshaw PT; Kwan ML; Xiao J; Alexeeff S; Corley D; Weltzien E; Castillo AL; Caan BJ
JAMA Oncol; 2017 Dec; 3(12):e172319. PubMed ID: 28796857
[TBL] [Abstract][Full Text] [Related]
10. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma.
Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T
Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-Induced Reduction of Neutrophil-to-Lymphocyte Ratio Is Associated With Better Survival in Pancreatic Adenocarcinoma: A Meta-Analysis.
Luo X; Yu B; Jiang N; Du Q; Ye X; Li H; Wang WQ; Zhai Q
Cancer Control; 2020; 27(1):1073274820977135. PubMed ID: 33269614
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer.
Qi Q; Geng Y; Sun M; Wang P; Chen Z
Pancreatology; 2015; 15(2):145-50. PubMed ID: 25641673
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-lymphocyte ratio and nutritional status are clinically useful in predicting prognosis in colorectal cancer patients.
Silva TH; Schilithz AOC; Peres WAF; Murad LB
Nutr Cancer; 2020; 72(8):1345-1354. PubMed ID: 31665931
[No Abstract] [Full Text] [Related]
14. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.
Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE
Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330
[TBL] [Abstract][Full Text] [Related]
15. The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.
Cheng H; Luo G; Lu Y; Jin K; Guo M; Xu J; Long J; Liu L; Yu X; Liu C
Pancreatology; 2016; 16(6):1080-1084. PubMed ID: 27665172
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.
Wang DS; Luo HY; Qiu MZ; Wang ZQ; Zhang DS; Wang FH; Li YH; Xu RH
Med Oncol; 2012 Dec; 29(5):3092-100. PubMed ID: 22476808
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer.
Kos FT; Hocazade C; Kos M; Uncu D; Karakas E; Dogan M; Uncu HG; Ozdemir N; Zengin N
Asian Pac J Cancer Prev; 2015; 16(9):3997-4002. PubMed ID: 25987075
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
[TBL] [Abstract][Full Text] [Related]
19. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
20. Association of systemic inflammation and body mass index with survival in patients with resectable gastric or gastroesophageal junction adenocarcinomas.
Gao X; Pan Y; Han W; Hu C; Wang C; Chen L; Guo Y; Shi Y; Pan Y; Xie H; Yao L; Yang J; Zheng J; Li X; Liu X; Hong L; Li J; Li M; Ji G; Li Z; Xia J; Zhao Q; Fan D; Wu K; Nie Y
Cancer Biol Med; 2021 Feb; 18(1):283-297. PubMed ID: 33628601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
